MobileLink: Patients who receive a MobileLink hip prosthesis system will be followed-up for 10 years.
Study summary
The implantation of artificial hip joints is one of the most frequently performed surgeries. Normally, patients are very satisfied with the results.
The MobileLink hip prosthesis system is a CE marked medical device. This means the the safety and performance of the prosthesis ist approved. Aim of the study is to collect clinical data about the outcome of the MobileLink hip prosthesis system under routine condition and to determine the satisfaction of the patients.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Implantation of a MobileLink acetabular cup system and a femoral stem manufactured by Waldemar Link
* Age ≥ 18 years
* Fully signed patient informed cons
Exclusion Criteria:
* Revisions
* Body Mass Index (BMI) ≥ 40 kg/m²
* Patient who is foreseeable not able to understand the study and the study-related circumstances
* Patients who is foreseeable non-compliant to the treatment and the follow-ups
* Pregnant or breast-feeding women
* Prisoner
Primary outcome measure(s)
Survival rate of the complete MobileLink hip prosthesis system with revision for any reason as the endpoint, — 10-years calculated with Kaplan-Meier method.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.